DUBLIN--(BUSINESS WIRE)--Sep 6, 2018--The "Global Oligonucleotide Synthesis Market - Segmented by Application, End-User and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.

The oligonucleotide synthesis market is expected to grow at a CAGR of 10.9% during the forecast period.

Increasing Government Investments and R&D Expenditure in Pharmaceutical & Biotechnology Companies

The rise in R&D spending by government and private entities is one of the factors that can explain the recent up rise in the innovation across all areas of the biotech industry. This includes major advances in biological sciences and pharmaceuticals, and the introduction of more effective drugs and curative and preventive treatments aimed at enhancing the quality of human life.Particularly, a rise in incidence of chronic illnesses due to an increase in aging population will continue to drive advancements in drug aimed at oncology and gene therapy to prevent and treat chronic illnesses.Recent legislative developments such as the 21st Century Cures Act, aimed at streamlining FDA approval processes will add to the speed of development and innovation of novel drugs and biotechnology products that can deliver efficacious drug therapies in the sector. This will help to drive the market with a higher CAGR in the forecasted period.Notable HighlightsPrice Erosion of Synthesized Oligonucleotides - Hampering GrowthNorth America to Maintain the Lead in the Global Market

Key Development in the Market

A conference was held which incorporated dialogue between regulators and industry from Chemistry Manufacturing and Controls (CMC), Nonclinical, Clinical Pharmacology, and Clinical disciplines to address the developmental advances, safety, and challenges in the field of oligonucleotide-based therapeutics.Companies FeaturedAgilent TechnologiesATDBioBioAutomationEurofins GenomicsEurogentecGE HealthcareGenScriptIntegrated DNA TechnologiesMerck KGaAThermo Fisher Scientific

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/b8p2zb/oligonucleotide?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180906005420/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Genomics

KEYWORD:

INDUSTRY KEYWORD: HEALTH GENETICS

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/06/2018 07:18 AM/DISC: 09/06/2018 07:18 AM

http://www.businesswire.com/news/home/20180906005420/en